Bio Blast Pharma backs its muscle wasting drug

According to interim results from
a mid-stage study, drug developer Bio
Blast Pharma Ltd said its drug
showed signs of being effective
in treating patients with a rare muscle wasting disorder.

Congrat to Bio
Blast Pharma Ltd because they have put a lot of effort in research and
manufacturing to be able to come out with such an effective drug
against muscle wasting.


Popular posts from this blog

Pfizer and Merck KGaA suffered another setback with immuno-oncology med Bavencio

Alzheimer’s disease reversed in mice, offering hope for humans

The U.S. Food and Drug Administration granted approval for expanded use of Imfinzi to treat non-small cell lung cancer (NSCLC) patients